Product Information
CIPROFLOXACIN HCL 250 MG TAB is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0842 per EA under NDC 16571041110. Its NADAC has been published 619 times since Nov 28, 2013.
Strength
250 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571041110
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CIPROFLOXACIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076639On Market Since
9/10/2004
Pharmacological Classes
Price Statistics
The NADAC for CIPROFLOXACIN HCL 250 MG TAB has been published 619 times since Nov 28, 2013, and over the history we have for it it has declined 33.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0842 per EA |
|---|---|
| All-time high | $0.1749 (Jun 10, 2015) |
| All-time low | $0.0811 (Nov 20, 2024) |
| 52-week high | $0.0917 |
| 52-week low | $0.0842 |
| Median price | $0.1003 |
| Average price | $0.1101 |
| Largest weekly change | -21.4% (Apr 17, 2024) |
| Weeks tracked | 619 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the ciprofloxacin market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of CIPROFLOXACIN HCL 250 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for CIPROFLOXACIN HCL 250 MG TAB, manufactured by Rising Pharma Holdings Inc., is $0.0842 per EA (NDC 16571041110), effective Jun 24, 2026.
How has the price of CIPROFLOXACIN HCL 250 MG TAB changed over time?
Over the history we have for it, the NADAC for CIPROFLOXACIN HCL 250 MG TAB has declined 33.7%. It has been tracked across 619 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CIPROFLOXACIN HCL 250 MG TAB?
Since Nov 28, 2013, the NADAC for CIPROFLOXACIN HCL 250 MG TAB has ranged from a low of $0.0811 (Nov 20, 2024) to a high of $0.1749 (Jun 10, 2015), with a median of $0.1003 per EA.
Are there cheaper alternatives to CIPROFLOXACIN HCL 250 MG TAB?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CIPROFLOXACIN HCL 250 MG TAB, so no direct lower-cost alternative is listed.
Who manufactures CIPROFLOXACIN HCL 250 MG TAB?
CIPROFLOXACIN HCL 250 MG TAB (NDC 16571041110) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification